Canntab Therapeutics Limited Stock Canadian Securities Exchange

Stocks

24-04-14

23-09-18	Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	NE
22-08-02	CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	PR
22-05-30	CANNTAB ANNOUNCES CHANGE OF AUDITOR	PR
22-03-23	CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED	PR
22-01-20	CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM	PR

Manager	Title	Age	Since
Joshi Laxminarayan CTO	Chief Tech/Sci/R&D Officer	-	2020-05-14
Frank Candido IRC	Investor Relations Contact	61	2018-08-31
Eric Malinski SAM	Sales & Marketing	-	2018-04-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNTAB THERAPEUTICS LIMITED	-.--%	-.--%	-	-	38
YUNNAN BAIYAO GROUP CO.,LTD	+0.04%	+1.46%	-13.03%	-6.44%	12.76B
BEIJING TONGRENTANG CO., LTD	+1.34%	+0.65%	-34.33%	-56.33%	4.72B
DONG-E-E-JIAO CO., LTD.	+0.15%	+2.06%	-8.54%	-4.43%	4.41B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+1.14%	+4.30%	+22.79%	-2.44%	3.89B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+0.52%	+0.20%	+4.48%	-38.18%	3.78B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+3.03%	+5.92%	-8.04%	-13.49%	3.22B
TASLY PHARMACEUTICAL GROUP CO., LTD	+0.21%	+3.38%	-11.41%	+2.48%	3.09B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+3.96%	+4.58%	-4.78%	-21.76%	2.44B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+2.10%	+9.66%	-5.56%	+44.84%	1.81B
Average	+1.25%	+2.23%	-6.49%	-10.64%	4.46B
Weighted average by Cap.	+0.94%	+1.31%	-8.55%	-13.18%